Medical Bulletin 10/January/2026 Anshika Mishra10 Jan 2026 3:00 PM ISTHere are the top medical news for today:Review suggests most GLP-1 users regain weight within two years after stopping Weight loss drugs work wonders...
Review suggests most GLP-1 users regain weight within two years after stopping Anshika Mishra10 Jan 2026 8:00 AM ISTWeight loss drugs work wonders for shedding pounds, but stopping them can bring the weight back faster than ever. A new University of Oxford review...
Online Platform Offers India-Sourced Ozempic to US Consumers at Steep Discounts sheeba farhat9 Jan 2026 11:28 PM ISTBengaluru: Online pharmacy platform SaveRxCanada.to said on Wednesday it has begun offering Novo Nordisk's blockbuster diabetes drug, Ozempic,...
Sun Pharma Agrees to Halt India Sales of Semaglutide After Delhi HC Records Patent Undertaking Susmita Roy11 Dec 2025 4:08 PM ISTNew Delhi: The Delhi High Court on Wednesday recorded a categorical undertaking from Sun Pharma that it will not market or sell its semaglutide...
Semaglutide Patent War: After Dr Reddy's Blow, Novo Nordisk Moves Delhi HC Against Sun Pharma Susmita Roy9 Dec 2025 5:00 PM ISTNew Delhi: In an escalation of India's unfolding GLP-1 patent war, Novo Nordisk has approached the Delhi High Court to restrain Sun Pharmaceutical...
New fat-burning diabetes pill protects muscle and appetite, reports research Dr. Kamal Kant Kohli8 Dec 2025 8:00 PM ISTLowering blood sugar and increasing fat burning without reducing appetite or muscle mass is emerging as a promising possibility in the treatment of...
Semaglutide Patent Clash: Delhi HC Denies Novo Nordisk Injunction, Manufacturing by Dr Reddy's to Continue Susmita Roy5 Dec 2025 10:28 PM ISTNew Delhi: In a significant development in the high-stakes patent litigation over diabetes blockbuster Semaglutide, the Delhi High Court has refused...
Tradipitant may Reduce Semaglutide-Induced Nausea and Vomiting, reports research Dr. Kamal Kant Kohli21 Nov 2025 8:00 PM ISTIn a randomized trial of adults with obesity or overweight, Vanda Pharmaceuticals' investigational NK-1 receptor antagonist tradipitant significantly...
From Launch to Leadership: Mounjaro Crosses Rs 333 Crore, Becomes India's Top-Selling Drug Farhat Nasim8 Nov 2025 5:06 PM ISTNew Delhi: Eli Lilly's diabetes and obesity drug Mounjaro (Tirzepatide) has become India's top-selling drug by value for October 2025, overtaking...
Medical Bulletin 28/October/2025 Anshika Mishra28 Oct 2025 3:00 PM ISTHere are the top medical news for the day:Study explores health risks of ultra-processed plant foods vs meat An in-depth narrative review in Current...
Weight-loss drugs like Ozempic may help reduce drug and alcohol addiction risks: Study Anshika Mishra28 Oct 2025 8:15 AM ISTResearchers have identified Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs)—medications already used for diabetes and obesity—as promising...
Weight-loss drugs may also curb drug and alcohol addiction, finds study Dr. Kamal Kant Kohli27 Oct 2025 9:00 PM ISTA promising group of medications already used to treat diabetes and obesity may also hold potential for tackling alcohol and drug addiction, according...
